138 related articles for article (PubMed ID: 11813617)
1. The significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severity.
Nikou GC; Arnaoutis TP; Giamarellos-Bourboulis EJ; Samolada O; Vafiadis-Zouboulis I; Katsilambros N; Arvanitakis C
Hepatogastroenterology; 2001; 48(42):1754-7. PubMed ID: 11813617
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
Paran H; Neufeld D; Mayo A; Shwartz I; Singer P; Kaplan O; Skornik Y; Klausner J; Freund U
J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
[TBL] [Abstract][Full Text] [Related]
3. High dose octreotide in the management of acute pancreatitis.
Karakoyunlar O; Sivrel E; Tanir N; Deneçli AG
Hepatogastroenterology; 1999; 46(27):1968-72. PubMed ID: 10430379
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
[TBL] [Abstract][Full Text] [Related]
5. Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis.
Nikou GC; Giamarellos-Bourboulis EJ; Grecka P; Toumpanakis Ch; Giannikopoulos G; Katsilambros N
Hepatogastroenterology; 2004; 51(56):599-602. PubMed ID: 15086213
[TBL] [Abstract][Full Text] [Related]
6. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
[TBL] [Abstract][Full Text] [Related]
7. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-term octreotide therapy and total parenteral nutrition on the development of biliary sludge and lithiasis.
Baudet S; Medina C; Vilaseca J; Guarner L; Sureda D; Andreu J; Malagelada JR
Hepatogastroenterology; 2002; 49(45):609-12. PubMed ID: 12063951
[TBL] [Abstract][Full Text] [Related]
9. [Effect of octreotide on the clinical course of acute pancreatitis and levels of free oxygen radicals and antioxidants].
Lata J; Dítĕ P; Julínková K; Precechtĕlová M; Prásek J
Vnitr Lek; 1998 Sep; 44(9):524-7. PubMed ID: 10358462
[TBL] [Abstract][Full Text] [Related]
10. Changes of plasma levels of gastrointestinal peptides over the course of acute pancreatitis. Any significance for the pathophysiology and treatment of acute pancreatitis?
Nikou GC; Giamarellos-Bourboulis EJ; Toumpanakis C; Arnaoutis TP; Kitsou E; Kyriaki D; Katsilambros N
Hepatogastroenterology; 2002; 49(45):706-8. PubMed ID: 12063974
[TBL] [Abstract][Full Text] [Related]
11. Effects of octreotide on acute pancreatitis of varying severity in rats.
Küçüktülü U; Alhan E; Erçin C; Cinel A; Calik A
Eur J Surg; 1999 Sep; 165(9):891-6. PubMed ID: 10533767
[TBL] [Abstract][Full Text] [Related]
12. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
Kisli E; Baser M; Aydin M; Guler O
Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
[TBL] [Abstract][Full Text] [Related]
13. Extensive hemorrhagic erosive gastritis associated with acute pancreatitis successfully treated with a somatostatin analog.
Yabuki K; Maekawa T; Satoh K; Tamasaki Y; Maekawa H; Kudoh K; Aoki E
J Gastroenterol; 2002; 37(9):737-41. PubMed ID: 12375148
[TBL] [Abstract][Full Text] [Related]
14. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
Topkan E; Karaoglu A
Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
[TBL] [Abstract][Full Text] [Related]
15. Octreotide in the treatment of acute pancreatitis: results of a unicenter prospective trial with three different octreotide dosages.
Binder M; Uhl W; Friess H; Malfertheiner P; Büchler MW
Digestion; 1994; 55 Suppl 1():20-3. PubMed ID: 8132134
[TBL] [Abstract][Full Text] [Related]
16. The effects of somatostatin on the microperfusion of the pancreas during acute necrotizing pancreatitis in rats.
Piri M; Alhan E; Küçüktülü U; Erçin C; Deger O; Yücel K; Cicek R
Hepatogastroenterology; 2002; 49(45):833-7. PubMed ID: 12064001
[TBL] [Abstract][Full Text] [Related]
17. Effects of octreotide in acute hemorrhagic necrotizing pancreatitis in rats.
Wenger FA; Kilian M; Heukamp I; Foitzik T; Jacobi CA; Guski H; Schimke I; Müller JM
J Gastroenterol Hepatol; 2007 Nov; 22(11):1872-6. PubMed ID: 17914962
[TBL] [Abstract][Full Text] [Related]
18. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
[TBL] [Abstract][Full Text] [Related]
19. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial.
Carcoforo P; Soliani G; Maestroni U; Donini A; Inderbitzin D; Hui TT; Lefor A; Avital I; Navarra G
J Am Coll Surg; 2003 Mar; 196(3):365-9. PubMed ID: 12648685
[TBL] [Abstract][Full Text] [Related]
20. Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
Turner HE; Thornton-Jones VA; Wass JA
Clin Endocrinol (Oxf); 2004 Aug; 61(2):224-31. PubMed ID: 15272918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
